The global chronic obstructive pulmonary disease market size is calculated at USD 23.55 billion in 2025 and is expected to ...

Decreased levels of resolvin D1 are linked to prolonged respiratory symptoms and slower clinical recovery in patients with ...

Medically reviewed by Sanja Jelic, MD Asthma and chronic obstructive pulmonary disease (COPD) are chronic respiratory (lung) ...

Following recent approvals in the EU, China and the U.S., this approval was based on pivotal Phase 3 results in adults with elevated eosinophils Approval marks the first new treatment approach for ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

An Osaka Metropolitan University medical research team aimed to investigate the effects of respiratory muscle dysfunction on clinical outcomes related to chronic obstructive pulmonary disease (COPD).

The following is a summary of “Point-of-care testing reduces antibiotic prescribing in acute exacerbations of chronic ...

A research team led by the Guangzhou Institutes of Biomedicine and Health of the Chinese Academy of Sciences has constructed ...

The global lung disease therapeutics market is on an impressive growth trajectory, projected to soar to USD 152,369.26 million by 2033, up from USD 83,398.60 million in 2023. This significant increase ...

People who live with chronic diseases such as chronic obstructive pulmonary disease (COPD), congestive heart failure (CHF), connective tissue diseases (CTD), chronic kidney disease (CKD), liver ...